EPIC trial ended

The EPIC trial data has now been published and shown significant benefit of pimobendan vs placebo in cases of advanced preclinical mitral valve disease, prolonging time to the development of symptoms and increasing longevity. This is very [...]

Angiostrongylus alert

We have seen a few cases of angiostrongylus (so called lung worm or french heart worm) recently. In all cases the dogs were referred for investigation of known heart disease that was not responding to [...]

Hope for Dobermanns

The results of the PROTECT trial investigating the efficacy of the drug pimobendan in Dobermanns with sub-clinical heart disease (disease with no symptoms) has now been published. Dogs on the trial that were receiving pimobendan [...]